1. United States
2. Ohio
3. Letter

I am writing as your constituent to urge you to publicly oppose and reject the nomination of Dr. Heidi Overton to serve as Commissioner of the Food and Drug Administration (FDA). The FDA oversees more than twenty percent of all consumer spending in the United States, regulating products vital to public health, medical safety, and economic stability. Leading an agency of approximately 16,000 scientists, physicians, and regulatory specialists requires proven institutional governance and unwavering scientific independence. Dr. Overton lacks both the executive track record to steer a massive federal agency and the independence the role demands, with administration insiders telling reporters she was chosen specifically because she is a "loyalist" who "goes along with things." During her confirmation hearing before the Senate HELP Committee, Dr. Overton repeatedly demonstrated that exact pattern of deference: - Refusal to Correct Misinformation: Dr. Overton affirmed that vaccines currently on the U.S. market are safe and effective. However, under direct questioning from Committee Chairman Bill Cassidy—a physician—she repeatedly declined to state whether public claims linking vaccines or Tylenol during pregnancy to autism were scientifically inaccurate, despite overwhelming medical consensus disproving any link. - Deference Over Established Medical Data: Despite decades of clinical data establishing the safety profile of medication abortion, Dr. Overton previously co-authored policy papers labeling mifepristone "dangerous." When questioned on whether she agrees with the FDA's existing safety data and would preserve current access standards, she refused to give a personal assessment or commit to evidence-based continuity, prompting Republican Senator Lisa Murkowski to express concern that ongoing agency reviews are being driven by political pressure. - Disavowal of Core Portfolio Decisions: Asked about reported administrative plans to accelerate authorizations for flavored vapes and nicotine products, Dr. Overton claimed she was completely unaware of the decision-making—a troubling gap in situational awareness for a nominee embedded in executive health policy. - Lack of Executive and Administrative Experience: Dr. Overton has never managed a major government bureaucracy, healthcare system, or scientific regulatory body of comparable scale, taking the helm at an agency requiring experienced, steady governance. The American public, healthcare providers, and the medical research community require an FDA Commissioner who adheres strictly to statutory safety standards, protects scientific integrity, and exercises independent judgment. An administration insider has already confirmed this nominee was selected specifically because she will not. I urge you to exercise congressional oversight, speak out publicly against this nominee, and vote against Dr. Heidi Overton’s confirmation.